Common Stock

12 Months Ended

Dec. 31, 2025

Stockholders' Equity Note [Abstract]

Common Stock

Common Stock

In 2016, the Company reserved 250,000 shares of its common stock to be made available to directors and employees who elect to participate in the stock purchase or savings and investment plans. As of December 31, 2025, 150,228 shares had been issued pursuant to these plans, leaving 99,772 shares available for future use. The issuance price is based on the market price of the stock at issuance date. Sales of stock to directors and employees amounted to 20,028 shares in 2025, 18,535 shares in 2024, and 17,472 shares in 2023.

In 2001, the Company established a dividend reinvestment plan to allow shareholders to use their cash dividends for the automatic purchase of shares in the Company. The plan was amended in 2018 to reflect changes in its administration. When the plan was established, 600,000 shares were registered with the Securities and Exchange Commission, and as of December 31, 2025, 363,633 shares have been issued, leaving 236,367 shares available for future issuance. Participation in this plan is optional and at the individual discretion of each shareholder. Shares are purchased for the plan from the Company at a price per share equal to the average of the daily bid and asked prices reported on the NASDAQ System for the five trading days immediately preceding, but not including, the dividend payment date. Sales of stock under the dividend reinvestment plan amounted to 16,619 shares in 2025, 15,908 shares in 2024, and 14,418 shares in 2023.

Proceeds from issuances of common stock under these plans totaled $916,000, $867,000 and $817,000 for the years ended December 31, 2025, 2024 and 2023, respectively.